Commonwealth Equity Services’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Commonwealth Equity Services's GOSS Position: Q2 2026 in Review
Commonwealth Equity Services reduced its Gossamer Bio (GOSS) stake by 7.3% in Q2 2026, selling an estimated $2.23K and leaving 101,993 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4376.
Commonwealth Equity Services first reported a position in GOSS in Q4 2023 and has held it in 11 quarters since. The position peaked at $244K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Commonwealth Equity Services held 101,993 shares of Gossamer Bio worth $16.8K as of Q2 2026.
- Commonwealth Equity Services sold 7,985 Gossamer Bio shares in Q2 2026, an estimated $2.23K.
- Gossamer Bio made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4376 holding.
- Commonwealth Equity Services first reported a position in Gossamer Bio in Q4 2023 and has held it in 11 quarters since.
- Commonwealth Equity Services's Gossamer Bio position peaked at $244K in Q4 2025.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.